Arama Sonuçları - Jean‐Pascal Machiels

Sonuçları Daraltın
  1. 1
    Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer

    Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer Yazar: Sandra Schmitz, Gabriela Bindea, Roxana Irina Albu, Bernhard Mlecnik, Jean‐Pascal Machiels

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact

    Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact Yazar: Natasha Honoré, Rachel Galot, Cédric van Marcke, Nisha Limaye, Jean‐Pascal Machiels

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery

    Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery Yazar: Patrice Forget, C. Bentin, Jean-Pascal Machiels, Martine Berlière, Pierre G. Coulie, Marc De Kock

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis

    Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis Yazar: Patrice Forget, J. Vandenhende, Martine Berlière, Jean‐Pascal Machiels, Benoît Nussbaum, Catherine Legrand, Marc De Kock

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Advances in the management of squamous cell carcinoma of the head and neck

    Advances in the management of squamous cell carcinoma of the head and neck Yazar: Jean‐Pascal Machiels, Maarten Lambrecht, François‐Xavier Hanin, Thierry Duprez, Vincent Grégoire, Sandra Schmitz, Marc Hamoir

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  6. 6
    A kernel-based integration of genome-wide data for clinical decision support

    A kernel-based integration of genome-wide data for clinical decision support Yazar: Anneleen Daemen, Olivier Gevaert, Fabian Ojeda, Annelies Debucquoy, Johan A. K. Suykens, Christine Sempoux, Jean‐Pascal Machiels, Karin Haustermans, Bart De Moor

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  7. 7
    One‐step TNM staging of high‐risk prostate cancer using magnetic resonance imaging (MRI): Toward an upfront simplified “all‐in‐one” imaging approach?

    One‐step TNM staging of high‐risk prostate cancer using magnetic resonance imaging (MRI): Toward an upfront simplified “all‐in‐one” imaging approach? Yazar: Vasiliki Pasoglou, A. Larbi, Laurence Collette, Laurence Annet, François Jamar, Jean‐Pascal Machiels, Nicolas Michoux, Bruno C. Vande Berg, Bertrand Tombal, Frédéric Lecouvet

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  8. 8
    A single‐arm, multicenter, open‐label phase 2 study of lapatinib as the second‐line treatment of patients with locally advanced or metastatic transitional cell carcinoma

    A single‐arm, multicenter, open‐label phase 2 study of lapatinib as the second‐line treatment of patients with locally advanced or metastatic transitional cell carcinoma Yazar: Christian Wülfing, Jean‐Pascal Machiels, D. J. Richel, Marc‐Oliver Grimm, Uwe Treiber, Marco R. de Groot, Philippe Beuzeboc, Roma Parikh, Frank Pétavy, Iman El‐Hariry

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)

    Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040) Yazar: Sara I. Pai, Sandrine Faivre, Lisa Licitra, Jean-Pascal Machiels, Jan B. Vermorken, Paolo Bruzzi, Viktor Gruenwald, R. Giglio, C. René Leemans, Tanguy Y. Seiwert, Denis Soulières

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Phase II Study of Sunitinib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: GORTEC 2006-01

    Phase II Study of Sunitinib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: GORTEC 2006-01 Yazar: Jean‐Pascal Machiels, Stéphanie Henry, Sylvie Zanetta, Marie‐Christine Kaminsky, Nicolas Michoux, Denis Rommel, Sandra Schmitz, Emmanuelle Bompas, Anne-Françoise Dillies, Sandrine Faivre, Anne Moxhon, Thierry Duprez, J. Guigay

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  11. 11
    Cancer risk in immune-mediated inflammatory diseases (IMID)

    Cancer risk in immune-mediated inflammatory diseases (IMID) Yazar: Rudi Beyaert, Laurent Beaugerie, Gert Van Assche, Liève Brochez, Jean‐Christophe Renauld, M. Viguier, Véronique Cocquyt, Guy Jérusalem, Jean‐Pascal Machiels, Hans Prenen, Pierre Masson, Édouard Louis, Filip De Keyser

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5‐fluorouracil or carboplatin/paclitaxel for first‐line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck

    Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5‐fluorouracil or carboplatin/paclitaxel for first‐line treatment of recurrent/metastatic squamous cell carcinoma of the... Yazar: Antonio Jimeno, Jean‐Pascal Machiels, Lori J. Wirth, Pol Specenier, Tanguy Y. Seiwert, F. Mardjuadi, Xiaodong Wang, Amy V. Kapp, S. Royer-Joo, Elicia Penuel, Bruce McCall, Andrea Pirzkall, Paul Clement

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)

    A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE) Yazar: Jean‐Pascal Machiels, Ramón Salazar, Sylvie Rottey, Ignacio Durán, Luc Dirix, Karen Geboes, Christine Wilkinson-Blanc, G. Pover, Simon Alvis, Brian Champion, Kerry Fisher, Hilary McElwaine-Johnn, John Beadle, Emiliano Calvo

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer

    Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and n... Yazar: Jammbe Z. Musoro, Corneel Coens, Susanne Singer, Silke Tribius, Sjoukje F. Oosting, Mogens Grøenvold, Christian Simon, Jean‐Pascal Machiels, Vincent Grégoire, Galina Velikova, Kim Cocks, Mirjam A. G. Sprangers, Madeleine King, Andrew Bottomley

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    Molecular Response to Cetuximab and Efficacy of Preoperative Cetuximab-Based Chemoradiation in Rectal Cancer

    Molecular Response to Cetuximab and Efficacy of Preoperative Cetuximab-Based Chemoradiation in Rectal Cancer Yazar: Annelies Debucquoy, Karin Haustermans, Anneleen Daemen, Selda Aydın, Louis Libbrecht, Olivier Gevaert, Bart De Moor, Sabine Tejpar, William H. McBride, Freddy Penninckx, Pierre Scalliet, Christopher Stroh, Soetkin Vlassak, Christine Sempoux, Jean‐Pascal Machiels

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings

    A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings Yazar: Stéphane Oudard, Olivier Rixe, Benoit Beuselinck, Claude Linassier, Eugéniu Banu, Jean-Pascal Machiels, Marion Baudard, François Ringeisen, Thierry Velu, Marie‐Aude Lefrère‐Belda, Jean–Marc Limacher, Wolf H. Fridman, Michel Azizi, Bruce Acres, Éric Tartour

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Prospective Randomized Study Comparing Docetaxel, Estramustine, and Prednisone With Docetaxel and Prednisone in Metastatic Hormone-Refractory Prostate Cancer

    Prospective Randomized Study Comparing Docetaxel, Estramustine, and Prednisone With Docetaxel and Prednisone in Metastatic Hormone-Refractory Prostate Cancer Yazar: Jean‐Pascal Machiels, F Mazzeo, Marylène Clausse, Bertrand Filleul, Luc Marcelis, Brigitte Honhon, Lionel D’Hondt, Catherine Dopchie, Vincent Verschaeve, Lionel Duck, Didier Verhoeven, Peter Jousten, Marie-Alix Bonny, Anne-Marie Moxhon, Bertrand Tombal, Joseph Kerger

    Baskı/Yayın Bilgisi 2008
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer

    Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer Yazar: Neeraj Agarwal, Jean-Pascal Machiels, Cristina Suárez, Nancy Lewis, Michaela J. Higgins, Kari B. Wisinski, Ahmad Awada, Michela Maur, Mark N. Stein, Andy Hwang, Rebecca Mosher, Ernesto Wasserman, Gang Wu, Hefei Zhang, Renata Zieba, Mohamed Elmeliegy

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone

    Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase II Study and Biomarker Analysis with Rilotumumab plus Mitoxantrone and Prednisone Yazar: Charles J. Ryan, Mark Rosenthal, Siobhan Ng, Joshi J. Alumkal, Joel Picus, Gwénaëlle Gravis, Karim Fizazi, Frédéric Forget, Jean-Pascal Machiels, Sandy Srinivas, Min Zhu, Rui Tang, Kelly S. Oliner, Yizhou Jiang, Elwyn Loh, Sarita Dubey, Winald R. Gerritsen

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  20. 20
    Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types

    Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metast... Yazar: Caroline Lonez, Bikash Verma, Alain Hendlisz, Philippe Aftimos, Ahmad Awada, Eric Van Den Neste, Gaëtan Catala, Jean‐Pascal Machiels, Fanny Piette, Jason Brayer, David A. Sallman, Tessa Kerre, Kunle Odunsi, Marco L. Davila, David E. Gilham, Frédéric Lehmann

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: